计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| F651215-5mg |
5mg |
期货 ![]() |
| |
| F651215-10mg |
10mg |
期货 ![]() |
| |
| F651215-25mg |
25mg |
期货 ![]() |
| |
| F651215-50mg |
50mg |
期货 ![]() |
| |
| F651215-100mg |
100mg |
期货 ![]() |
|
| 规格或纯度 | ≥98% |
|---|---|
| 英文名称 | FTO-IN-8 |
| 生化机理 | FTO-IN-8(FTO-43)是一种 N6-甲基腺苷脱甲基酶(FTO)(脂肪量和肥胖相关蛋白)抑制剂,IC50 值为 5.5 μM。FTO-IN-8 具有抗癌细胞增殖活性。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 产品介绍 |
FTO-IN-8 (FTO-43) is a N6-methyladenosine demethylase ( FTO ) (fat mass- and obesity-associated protein) inhibitor with the IC 50 value of 5.5 μM. FTO-IN-8 has anti-cancer cell proliferative activity. In Vitro FTO-IN-8 (FTO-43) (0-50 μM, 24-72 h) inhibits the proliferation of cancer cells with no cytotoxicity to normal colonic cells. FTO-IN-8 (FTO-43) can increase m 6 A and m 6 A m levels and inhibits Wnt/PI3K-Akt signaling in gastric cancer AGS cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: AGS, SNU16, and KATOIII cell lines Concentration: 0-50 μM Incubation Time: 24, 48, 72 hours Result: Inhibited the growth of SNU16, KATOIII and AGS with the EC 50 values of 17.7 μM, 35.9 μM and 20.3 μM, respectively. Form:Oil |
| 纯度 | ≥98% |
| 分子量 | 346.85 |
|---|
| 溶解性 | DMSO : ≥ 100 mg/mL (288.31 mM) |
|---|